The Effect of an Opioid on the Lower Esophageal Sphincter During Anesthesia Induction

NCT01199458 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2016-11-09

No results posted yet for this study

Summary

This study evaluates the effects of adding an opioid (alfentanil) during anesthesia induction with respect to the barrierpressure in the esophagogastric junction.

The secondary aim was to investigate whether the effect of cricoid pressure influences the barrierpressure.

Conditions

  • Lower Esophageal Sphincter

Interventions

DRUG

alfentanil

20 mikrogr/kg

DRUG

saline

The amount of saline will be equal the amount (in ml) of the study-drug (alfentanil)in order to keep it blinded.

Sponsors & Collaborators

  • Region Örebro County

    lead OTHER

Principal Investigators

  • Magnus Wattwil, MD PhD · Department of Anesthesia and Intensive Care, Örebro University Hospital, Örebro,Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199458 on ClinicalTrials.gov